Ground-breaking medical research in a consortium led by two UK universities will explore new ways to diagnose lung cancer earlier and save lives.
The Universities of Southampton and Leeds have come together with healthcare, diagnostics and informatics companies to test the best way of detecting cancers at a stage when they can still be cured, linking to the NHS England Targeted Lung Health Checks programme. The research collaborators include the Lung Cancer Initiative at Johnson & Johnson, Roche, Oncimmune, Inivata, BC Platforms and others.
